⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RXRX News
Recursion Pharmaceuticals, Inc. Class A Common Stock
Global Small Molecule Drug Discovery Market (2026-2031) - Rising Pharmaceutical R&D Investment Drives Growth
globenewswire.com
AZN
EVO
EXEL
ICLR
LAB
PFE
RXRX
RLAY
TMO
AI Disrupts Topical Drug Delivery as Billion-Dollar Partnerships and $3.3 Billion in VC Funding Signal a Structural Shift in Pharmaceutical Formulation
globenewswire.com
LLY
RXRX
NVDA
NVS
SNY
SPRY
Generative AI in Clinical Trials Market to Hit USD 1,986.53 Billion by 2035 – SNS Insider
globenewswire.com
IQV
ORCL
MSFT
GOOG
AMZN
NVDA
VEEV
IBM
INSM
RXRX
AI Disruption Reshapes Bioinformatics: Record Investment and Breakthrough Tools Signal a New Era for Drug Discovery and Precision Medicine
globenewswire.com
GOOG
ILMN
TMO
AGNC
PACB
RXRX
ATOM
Form 8-K
sec.gov
RXRX
Recursion Reports Second Quarter Financial Results; Genentech Options First Neuroscience Target into Early Discovery Program
globenewswire.com
RXRX
RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties
globenewswire.com
RXRX
Recursion to Participate in Upcoming Investor Conferences
globenewswire.com
RXRX
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
globenewswire.com
RXRX
Recursion to Report Second Quarter 2026 Business Updates and Financial Results on August 5th
globenewswire.com
RXRX